Compare CRBU & UIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRBU | UIS |
|---|---|---|
| Founded | 2011 | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.7M | 164.7M |
| IPO Year | 2021 | 1994 |
| Metric | CRBU | UIS |
|---|---|---|
| Price | $2.32 | $2.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $10.75 | $5.67 |
| AVG Volume (30 Days) | ★ 1.2M | 622.5K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.64 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,950,100,000.00 |
| Revenue This Year | $1.63 | N/A |
| Revenue Next Year | $10.93 | $2.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.73 | $1.97 |
| 52 Week High | $3.53 | $5.33 |
| Indicator | CRBU | UIS |
|---|---|---|
| Relative Strength Index (RSI) | 67.38 | 75.67 |
| Support Level | $1.70 | $2.61 |
| Resistance Level | $2.66 | $2.89 |
| Average True Range (ATR) | 0.11 | 0.11 |
| MACD | 0.03 | 0.08 |
| Stochastic Oscillator | 94.85 | 95.57 |
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.
Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. maximum of revenue is from CA&I segment.